1.Disease activity of idiopathic pulmonary fibrosis: value of high resolution CT.
Jin Seong LEE ; Jung Gi IM ; Man Chung HAN ; Chu Wan KIM ; Jin Suk SUH
Journal of the Korean Radiological Society 1991;27(1):55-59
No abstract available.
Idiopathic Pulmonary Fibrosis*
2.Two cases of idiopathic pulmonary fibrosis.
Young Gyun OH ; Seoung Hwan KIM ; Mi Reong KIM ; Byung Kiu PARK ; Hee Shang YOUN ; Myung Kul YUM
Journal of the Korean Pediatric Society 1992;35(1):122-128
No abstract available.
Idiopathic Pulmonary Fibrosis*
3.Expression of intercelluar adhesion molecule-1 in human idiopathic pulmonary fibrosis.
Sung Soo PARK ; Dong Ho SHIN ; Tae Wha KIM ; Dong Hoo LEE ; Jung Hee LEE ; Jung Dal LEE
Tuberculosis and Respiratory Diseases 1993;40(2):185-191
No abstract available.
Humans*
;
Idiopathic Pulmonary Fibrosis*
4.Pirfenidone-Induced Photosensitivity in a Patient with Idiopathic Pulmonary Fibrosis.
Ho Jin KIM ; Jeong Wan SEO ; Tae Hoon KIM ; Seung Hwan CHOI ; Ki Hoon SONG ; Ki Ho KIM
Annals of Dermatology 2018;30(5):614-616
No abstract available.
Humans
;
Idiopathic Pulmonary Fibrosis*
5.An ROC study detecting ability of idiopathic pulmonary fibrosis using digital radiography.
Eun Chul CHUNG ; Jung Gi IM ; Man Chung HAN ; Jong Hyo KIM
Journal of the Korean Radiological Society 1991;27(2):259-265
No abstract available.
Idiopathic Pulmonary Fibrosis*
;
Radiographic Image Enhancement*
6.Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia.
Tuberculosis and Respiratory Diseases 1997;44(3):449-469
No abstract available.
Idiopathic Pulmonary Fibrosis*
;
Lung Diseases, Interstitial*
7.Clinical evaluation on idiopathic pulmonary fibrosis.
Journal of Central South University(Medical Sciences) 2021;46(3):309-315
Idiopathic pulmonary fibrosis (IPF) is a chronic fatal pulmonary disease characterized by complex illness condition. There is no effective treatment at present except lung transplantation. The comprehensive evaluation is helpful for the management of patients with IPF in hierarchical stages. Therefore, it is very important to evaluate IPF by various independent factors. At present, the commonly used methods for clinical evaluation on IPF include assessment of health-related quality of life, assessment of physiological function, assessment of imaging, assessment of laboratory examination, and multi-dimensional assessment system. However, there are different advantages and disadvantages on diverse evaluation methods for the evaluation of IPF.
Humans
;
Idiopathic Pulmonary Fibrosis/diagnosis*
;
Quality of Life
8.A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals.
Ha Ryong KIM ; Da Young SHIN ; Kyu Hyuck CHUNG
Environmental Health and Toxicology 2018;33(3):e2018014-
Several studies showed that the inflammatory and fibrotic responses induced by polyhexamethylene guanidine phosphate (PHMG-p) were similar to those observed for idiopathic pulmonary fibrosis in South Korea in 2011. “Omic” technologies can be used to understand the mechanisms underlying chemical-induced diseases. Studies to determine the toxicity of chemicals may facilitate understanding of the mechanisms underlying the development of pulmonary fibrosis at a molecular level; thus, such studies may provide information about the toxic characteristics of various substances. In this review, we have outlined the cellular and molecular mechanisms underlying idiopathic pulmonary fibrosis and described pulmonary fibrosis induced by various chemicals, including bleomycin, paraquat, and PHMG-p, based on the results of studies performed to date.
Bleomycin
;
Epithelial Cells
;
Guanidine
;
Idiopathic Pulmonary Fibrosis
;
Korea
;
MicroRNAs
;
Paraquat
;
Pulmonary Fibrosis*
9.A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals
Ha Ryong KIM ; Da Young SHIN ; Kyu Hyuck CHUNG
Environmental Health and Toxicology 2018;33(3):2018014-
Several studies showed that the inflammatory and fibrotic responses induced by polyhexamethylene guanidine phosphate (PHMG-p) were similar to those observed for idiopathic pulmonary fibrosis in South Korea in 2011. “Omic” technologies can be used to understand the mechanisms underlying chemical-induced diseases. Studies to determine the toxicity of chemicals may facilitate understanding of the mechanisms underlying the development of pulmonary fibrosis at a molecular level; thus, such studies may provide information about the toxic characteristics of various substances. In this review, we have outlined the cellular and molecular mechanisms underlying idiopathic pulmonary fibrosis and described pulmonary fibrosis induced by various chemicals, including bleomycin, paraquat, and PHMG-p, based on the results of studies performed to date.
Bleomycin
;
Epithelial Cells
;
Guanidine
;
Idiopathic Pulmonary Fibrosis
;
Korea
;
MicroRNAs
;
Paraquat
;
Pulmonary Fibrosis
Result Analysis
Print
Save
E-mail